Literature DB >> 15652385

Comparison of five different rat models of peripheral nerve injury.

Tom Dowdall1, Ian Robinson, Theo F Meert.   

Abstract

Described here is a comparison of five peripheral sciatic nerve injury models in rats which all result in various degrees of neuropathic pain symptoms. They are the chronic constriction injury (CCI), the spinal nerve ligation (SNL), the partial sciatic ligation (PSL), the tibial and sural transection (TST), and the complete sciatic transection (CST) model. Behavioral testing was performed on these models over a 56-day period under strict experimental conditions to minimise variability between the surgical models and to allow for an accurate evaluation of the sensory deficits produced by each model. Overall, all five models of neuropathic pain produced signs of allodynia and hyperalgesia to various stimuli. However, the duration and magnitude of the evoked responses varied considerably between the different models.

Entities:  

Mesh:

Year:  2004        PMID: 15652385     DOI: 10.1016/j.pbb.2004.10.016

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  40 in total

1.  Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats.

Authors:  Megan Ryan Detloff; Lesley C Fisher; Violetta McGaughy; Erin E Longbrake; Phillip G Popovich; D Michele Basso
Journal:  Exp Neurol       Date:  2008-04-20       Impact factor: 5.330

2.  Sciatic nerve transection modulates oxidative parameters in spinal and supraspinal regions.

Authors:  Taína Scheid; Lidiane Dal Bosco; Renata P Guedes; Maria Amália Pavanato; Adriane Belló-Klein; Wania A Partata
Journal:  Neurochem Res       Date:  2013-02-20       Impact factor: 3.996

3.  Depression-like behavior and mechanical allodynia are reduced by bis selenide treatment in mice with chronic constriction injury: a comparison with fluoxetine, amitriptyline, and bupropion.

Authors:  Cristiano R Jesse; Ethel A Wilhelm; Cristina W Nogueira
Journal:  Psychopharmacology (Berl)       Date:  2010-08-06       Impact factor: 4.530

Review 4.  Institutional animal care and use committee considerations for animal models of peripheral neuropathy.

Authors:  Thea Brabb; Larry Carbone; Jessica Snyder; Nona Phillips
Journal:  ILAR J       Date:  2014

5.  Anti-fibroblast growth factor-2 antibodies attenuate mechanical allodynia in a rat model of neuropathic pain.

Authors:  Francesca Madiai; Virginia M Goettl; Syed-Rehan Hussain; Alec R Clairmont; Robert L Stephens; Kevin V Hackshaw
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 6.  Predictive validity of behavioural animal models for chronic pain.

Authors:  Odd-Geir Berge
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

7.  Pharmacological and behavioral characterization of the saphenous chronic constriction injury model of neuropathic pain in rats.

Authors:  Ozgur Gunduz; Cagatay Oltulu; Rabia Guven; Dilek Buldum; Ahmet Ulugol
Journal:  Neurol Sci       Date:  2011-09-10       Impact factor: 3.307

8.  Hypolocomotion, asymmetrically directed behaviors (licking, lifting, flinching, and shaking) and dynamic weight bearing (gait) changes are not measures of neuropathic pain in mice.

Authors:  Jeffrey S Mogil; Allyson C Graham; Jennifer Ritchie; Sara F Hughes; Jean-Sebastien Austin; Ara Schorscher-Petcu; Dale J Langford; Gary J Bennett
Journal:  Mol Pain       Date:  2010-06-08       Impact factor: 3.395

Review 9.  Behavioral models of pain states evoked by physical injury to the peripheral nerve.

Authors:  Linda S Sorkin; Tony L Yaksh
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

10.  Comparison of dorsal root ganglion gene expression in rat models of traumatic and HIV-associated neuropathic pain.

Authors:  Klio Maratou; Victoria C J Wallace; Fauzia S Hasnie; Kenji Okuse; Ramine Hosseini; Nipurna Jina; Julie Blackbeard; Timothy Pheby; Christine Orengo; Anthony H Dickenson; Stephen B McMahon; Andrew S C Rice
Journal:  Eur J Pain       Date:  2008-07-07       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.